Nuclear Imaging Equipment - Market Insights, Competitive Landscape, and Market Forecast - 2032

Nuclear Imaging Equipment Market by Product Type (Single-Photon Emission Computerized Tomography (SPECT) and Positron Emission Tomography (PET)), Application (Oncology, Cardiology, Neurology, and Others), End-User (Hospitals, Diagnostic Imaging Centers, and Research Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a decent CAGR forecast till 2032 owing to the increasing cases of chronic disorders and growing product development activities worldwide.

The nuclear imaging equipment market was valued at USD 3.00 billion in 2024, growing at a CAGR of 4.96% during the forecast period from 2025 to 2032 to reach USD 4.41 billion by 2032. The nuclear imaging equipment market is witnessing rapid expansion, primarily driven by the rising cases of chronic disorders. These include heart conditions, various forms of cancer, bone diseases, gastrointestinal issues, and neurological disorders. Additionally, the market is benefiting from a surge in product development activities aimed at enhancing diagnostic accuracy and efficiency. The growing preference for minimally invasive procedures is further accelerating the adoption of nuclear imaging technologies. Collectively, these factors are expected to significantly boost the growth of the nuclear imaging equipment market during the forecast period from 2025 to 2032.

Nuclear Imaging Equipment Market Dynamics:

The Global Cancer Observatory (2024) estimated that the new instances of cancer globally would range from 20 million to 24.1 million by 2030. Moreover, it stated that Asia accounted for 9,826,539 cancer cases, Europe accounted for 4,471,422 cancer cases, Latin America accounted for 1,551,060 cancer cases, and Africa accounted for 1,185,216 cancer cases.

Nuclear imaging modalities like PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography) play a vital role in detecting, staging, and monitoring various cancers, including lung, breast, colorectal, and lymphoma. These imaging tools provide detailed insights into metabolic and molecular activity within tumors, allowing clinicians to differentiate between benign and malignant lesions, evaluate the extent of disease spread (metastasis), and assess the effectiveness of therapies over time, thereby boosting the overall market of nuclear imaging equipment.

The growing global burden of cardiovascular diseases is another major factor driving the expansion of the nuclear imaging equipment market. According to recent data from the British Heart Foundation (2025), approximately 7.6 million individuals in the UK are currently living with heart or circulatory diseases, including 2.3 million affected by coronary heart disease alone. Complementing this, the American Heart Association (2023) projected that by 2030, over 12 million people worldwide would be living with atrial fibrillation.

These conditions often require advanced imaging techniques for early diagnosis, disease monitoring, and treatment planning. Nuclear imaging technologies, such as SPECT and PET, offer detailed functional insights that are crucial in evaluating cardiac perfusion, viability, and rhythm abnormalities. As the prevalence of heart-related conditions continues to rise, the demand for accurate and non-invasive diagnostic tools is expected to grow, thereby accelerating the adoption and growth of the nuclear imaging equipment market.

Moreover, the increasing product development activities among the key market players, such as product approval or launch, are further escalating the overall market of nuclear imaging equipment market. For instance, in May 2025, GE HealthCare announced that it received FDA 510(k) clearance for its Aurora nuclear medicine system and Clarify DL, an advanced dual-head SPECT/CT designed to improve diagnostic accuracy and workflow efficiency.

Therefore, the factors stated above collectively will drive the overall nuclear imaging equipment market growth.

However, risks associated with the use of nuclear imaging equipment, strict regulations by the Nuclear Regulatory Commission (NRC), and others may prove to be challenging factors for the nuclear imaging equipment market growth.

Nuclear Imaging Equipment Market Segment Analysis:

Nuclear Imaging Equipment Market by Product Type (Single-Photon Emission Computerized Tomography (SPECT) and Positron Emission Tomography (PET)), Application (Oncology, Cardiology, Neurology, and Others), End-User (Hospitals, Diagnostic Imaging Centers, and Research Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the nuclear imaging equipment market, positron emission tomography (PET) is expected to capture a significant share of revenue in 2024. This strong market performance can be attributed to several key advantages that PET technology offers over other imaging modalities. One of its primary benefits lies in its superior sensitivity, up to two to three orders of magnitude higher than alternative techniques, enabling it to detect and record a much greater percentage of emitted events. This heightened sensitivity translates to improved image quality, better lesion detection, and more accurate diagnostics, particularly in oncology, neurology, and cardiology.

Furthermore, PET is considered a more flexible imaging modality due to the relative ease of synthesizing new radiotracers. This flexibility allows researchers and clinicians to tailor imaging agents to specific biological targets, making PET invaluable for personalized and precision medicine.

Ongoing innovation and product development by leading key players are also accelerating PET’s adoption. For instance, in June 2024, Siemens Healthineers introduced the Biograph Trinion, a next-generation, high-performance, and energy-efficient PET/CT scanner. This system is designed to deliver broad clinical versatility across various diagnostic applications while minimizing operational and maintenance costs over its lifetime.

Additionally, growing clinical demand for early and accurate disease diagnosis, combined with increasing investments in hybrid imaging systems such as PET/CT and PET/MRI, is further reinforcing PET’s role in the evolving landscape of nuclear imaging.

Therefore, the combination of advanced capabilities, expanding clinical utility, and continued technological advancements is expected to solidify PET’s significant impact on the overall growth of the nuclear imaging equipment market during the forecast period from 2025 to 2032.

North America is expected to dominate the overall nuclear imaging equipment market:

Among all the regions, North America is expected to dominate the nuclear imaging equipment market in the year 2024. This growth can be attributed to a combination of key factors, including the rising instances of cancer, cardiovascular diseases, and neurological disorders, among others, across the region and the increasing emphasis on oncology research, supported by favorable government policies and funding initiatives. These efforts are aimed at strengthening early detection, diagnosis, and treatment capabilities. Additionally, significant advancements in product development, particularly in hybrid imaging technologies and a streamlined regulatory approval process, are further propelling the adoption of nuclear imaging equipment. Collectively, these elements are driving sustained growth in the North American nuclear imaging equipment market throughout the forecast period from 2025 to 2032.

According to the Global Cancer Observatory’s data (2024), in 2022, the US represented 89.1% of all cancer cases, and Canada represented 10.9% of all cancer cases in the region. With the US expected to account for a substantial proportion of these cancer cases, healthcare providers are compelled to enhance their cancer treatment capabilities, leading to greater investment in advanced nuclear imaging equipment. This growing patient population necessitates innovative and effective treatment options, thereby expanding the market for the same.

Additionally, according to the Alzheimer’s Foundation (2024), over 7 million Americans were living with Alzheimer's. By 2050, this number was projected to rise to nearly 13 million. Nuclear imaging modalities, particularly PET scans, play a vital role by allowing clinicians to assess brain metabolism (FDG-PET) and amyloid plaque buildup using specialized tracers, which are hallmark features of Alzheimer’s. This functional imaging capability provides insights beyond what structural imaging like CT or MRI can offer, enabling better disease characterization and differentiation from other forms of dementia.

Moreover, the rising product development activities by regulatory bodies and key players in the region will further boost the market for nuclear imaging equipment. For example, in March 2022, at RSNA 2021, Philips, a health-tech company, highlighted the launch of two new cutting-edge CT systems, the multi-energy Spectral CT 7500 and the CT 5100 Incisive with integrated artificial intelligence.

Additionally, in March 2022, NeuroLogica Corp, a Samsung Electronics Co. Ltd. subsidiary, announced that its state-of-the-art OmniTom Elite received 510(k) clearance for the addition of Photon Counting Detector (PCD) technology. The company introduced the first single-source photon-counting computed tomography (CT) scanner with a single detector on a transportable device. OmniTom Elite with PCD is capable of producing spectral CT pictures at various energy levels.

Therefore, the interplay of all the aforementioned factors would provide a conducive growth environment for the North American nuclear imaging equipment market.

Nuclear Imaging Equipment Market Key Players:

Some of the key market players operating in the nuclear imaging equipment market include Siemens Healthcare Private Limited, GE HealthCare, Koninklijke Philips N.V., DIGIRAD CORPORATION, Neusoft Corporation, CANON MEDICAL SYSTEMS CORPORATION, SurgicEye GmbH, DDD-Diagnostic A/S, CMR Naviscan, Mediso Ltd., Shimadzu Corporation, MR Solutions, segamicorp, Spectrum Dynamics Medical, Cardinal Health, Curium SAS, BCL X-Ray Canada Inc., NeuroLogica Corp, Hitachi Medical Systems, Computerized Imaging Reference Systems Inc., and others.

Recent Developmental Activities in the Nuclear Imaging Equipment Market:

• In April 2025, Quantum BioPharma Ltd., a biopharmaceutical company focused on advancing a portfolio of innovative assets and biotech solutions, announced that it entered into a joint clinical study with scientists from Massachusetts General Hospital (MGH) as of March 31, 2025. The study aimed to validate a novel positron emission tomography (PET) imaging technique designed to monitor myelin integrity and detect demyelination in individuals with multiple sclerosis (MS).
• In May 2022, Mediso Ltd, a Hungarian manufacturer of nuclear medicine imaging equipment, announced the acquisition of Bartec Technologies Ltd., a UK-based company specializing in the supply, installation, and support of Nuclear Medicine and Molecular Imaging equipment and accessories.

Key takeaways from the nuclear imaging equipment market report study

• Market size analysis for the current nuclear imaging equipment market size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the nuclear imaging equipment market
• Various opportunities available for the other competitors in the nuclear imaging equipment market space
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current nuclear imaging equipment market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for the nuclear imaging equipment market growth in the coming future?

Target audience who can benefit from this nuclear imaging equipment market report study

• Nuclear imaging equipment product providers
• Research organizations and consulting companies
• Nuclear imaging equipment-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in nuclear imaging equipment
• Various end-users who want to know more about the nuclear imaging equipment market and the latest technological developments in the nuclear imaging equipment market

Frequently Asked Questions for the Nuclear Imaging Equipment Market:

1. What is nuclear imaging equipment?

• Nuclear imaging equipment includes a unique gamma camera and single-photon emission computed tomography (SPECT) imaging methods that are used in nuclear medicine. The gamma camera captures and transforms the energy emitted by the radiotracer in the body into a picture.

2. What is the market for nuclear imaging equipment?

• The nuclear imaging equipment market was valued at USD 3.00 billion in 2024, growing at a CAGR of 4.96% during the forecast period from 2025 to 2032 to reach USD 4.41 billion by 2032.

3. What are the drivers for the nuclear imaging equipment market?

• The nuclear imaging equipment market is witnessing rapid expansion, primarily driven by the rising cases of chronic disorders. These include heart conditions, various forms of cancer, bone diseases, gastrointestinal issues, and neurological disorders. Additionally, the market is benefiting from a surge in product development activities aimed at enhancing diagnostic accuracy and efficiency. The growing preference for minimally invasive procedures is further accelerating the adoption of nuclear imaging technologies. Collectively, these factors are expected to significantly boost the growth of the nuclear imaging equipment market during the forecast period from 2025 to 2032.

4. Who are the key players operating in the nuclear imaging equipment market?

• Some of the key market players operating in nuclear imaging equipment include Siemens Healthcare Private Limited, GE HealthCare, Koninklijke Philips N.V., DIGIRAD CORPORATION, Neusoft Corporation, CANON MEDICAL SYSTEMS CORPORATION, SurgicEye GmbH, DDD-Diagnostic A/S, CMR Naviscan, Mediso Ltd., Shimadzu Corporation, MR Solutions, segamicorp, Spectrum Dynamics Medical, Cardinal Health, Curium SAS, BCL X-Ray Canada Inc., NeuroLogica Corp, Hitachi Medical Systems, Computerized Imaging Reference Systems Inc., and others.

5. Which region has the highest share in the nuclear imaging equipment market?

• Among all the regions, North America is expected to dominate the nuclear imaging equipment market in the year 2024. This growth can be attributed to a combination of key factors, including the rising instances of cancer across the region and the increasing emphasis on oncology research, supported by favorable government policies and funding initiatives. These efforts are aimed at strengthening early detection, diagnosis, and treatment capabilities. Additionally, significant advancements in product development, particularly in hybrid imaging technologies and a streamlined regulatory approval process, are further propelling the adoption of nuclear imaging equipment. Collectively, these elements are driving sustained growth in the North American nuclear imaging equipment market throughout the forecast period from 2025 to 2032.

This product will be delivered within 2 business days.